Trademarkia Logo

Australia

AU$
Trademark Search
PHAIM AIM Antigenic Immune Modulation

View On IPO.GOV.AU

PHAIM AIM Antigenic Immune Modulation
Registered: Registered/protected

Last updated on 20 Dec 2021

Owner Info

Phaim Pharma Ltd

One Bartholomew Close

LONDON, EC1A 7BL UNITED KINGDOM,

Serial Number

2178737 filed on 13 May 2021

Correspondent

McCullough Robertson Lawyers

GPO Box 1855,

Brisbane, QLD, 4001 AUSTRALIA,

PHAIM AIM Antigenic Immune Modulation

Classification Information

Class [005]
Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations Read More

Class [010]
Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposes; Blood glucose testing apparatus; Apparatu Read More

Class [035]
Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertising, marketi Read More

Class [044]
Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical scree Read More

Mark Details

Serial Number

2178737

Registered On

13 May 2021

Renewal On

13 May 2031

Mark Type

WORD

Priority Claim (Convention Details)

Date

10 May 2021

Mark Type

GB

Legal History

Show more

Status DateAction Taken
20th Dec 2021IP Right Registered correspondence sent
20th Dec 2021IP Right Registration Published
20th Dec 2021Status change to Registered/Protected
11th Oct 2021Application Accepted correspondence sent
11th Oct 2021IP Right has been Examined
11th Oct 2021IP Right Acceptance Published
26th May 2021Early Acceptance Notice correspondence sent
26th May 2021Status change to Accepted
19th May 2021Awaiting examination
19th May 2021Examination expedited